+1-786-628-7980
Sign Up/Sign In 
As an organization, the major focus is to provide real-world data evidence and market insight to pharmaceutical companies for their decision-making. The disease progresses the median survival is three to five years, and only 5% of patients are alive five to ten years after symptom onset.
